ACP Response to CMS RFI on Medicare $2 Drug List Model

ACP offers feedback related to development, outreach efforts, and impact assessment of the Medicare $2 Drug List Model.

Danielle Sakowitz

CMS, Medicare, prescription drugs, drug list, Part D, CMMI, innovation center, prior authorization, $2 drug

Thu, 12/12/2024 - 9:46 AM EST

Tue, 12/17/2024 - 9:44 AM EST

2

acp_response_to_cms_rfi_on_medicare_2_drug_list_model_2024.pdf

{"Author":"Danielle Sakowitz","Comments":"","Company":"","ContentTypeId":"0x01010000C7A5BA1B1C5C4D85BB025581C509BC","CreationDate":"2024-12-12T09:46:42-05:00","Creator":"Acrobat PDFMaker 24 for Word","GrammarlyDocumentId":"cb29dfbebd87c666ff3720a9a9d1b947615c935f8fa42a291ef12c011543ae82","Keywords":"CMS, Medicare, prescription drugs, drug list, Part D, CMMI, innovation center, prior authorization, $2 drug ","MediaServiceImageTags":"","ModDate":"2024-12-17T09:44:24-05:00","Producer":"Adobe PDF Library 24.4.48","SourceModified":"2024-12-09T21:44:53+00:00","Subject":"","Title":"ACP Response to CMS RFI on Medicare $2 Drug List Model","Pages":2,"xmp:modifydate":"2024-12-17T09:44:24-05:00","xmp:createdate":"2024-12-12T09:46:42-05:00","xmp:metadatadate":"2024-12-17T09:44:24-05:00","xmp:creatortool":"Acrobat PDFMaker 24 for Word","xmpmm:documentid":"uuid:2f9da0d0-b8eb-4eb8-9598-ab553c5ec1a4","xmpmm:instanceid":"uuid:4725ff5a-3b0b-4aab-b01e-5ce78f9b1bf4","xmpmm:subject":"5","dc:format":"application\/pdf","dc:title":"ACP Response to CMS RFI on Medicare $2 Drug List Model","dc:description":"","dc:creator":"Danielle Sakowitz","dc:subject":["CMS","Medicare","prescription drugs","drug list","Part D","CMMI","innovation center","prior authorization","$2 drug"],"pdf:producer":"Adobe PDF Library 24.4.48","pdf:keywords":"CMS, Medicare, prescription drugs, drug list, Part D, CMMI, innovation center, prior authorization, $2 drug ","pdfx:sourcemodified":"D:20241209214453","pdfx:contenttypeid":"0x01010000C7A5BA1B1C5C4D85BB025581C509BC","pdfx:grammarlydocumentid":"cb29dfbebd87c666ff3720a9a9d1b947615c935f8fa42a291ef12c011543ae82"}

2024